Topoisomerase I Inhibitors
- Name
- Topoisomerase I Inhibitors
- Accession Number
- DBCAT001116
- Description
Compounds that inhibit the activity of DNA TOPOISOMERASE I.
- Drugs
Drug Drug Description Irinotecan A topoisomerase inhibitor used to treat metastatic carcinoma of the colon or rectum and pancreatic adenocarcinoma. Topotecan An antineoplastic agent used to treat ovarian cancer, small cell lung cancer, or cervical cancer. Camptothecin Investigated for the treatment of cancer. Rubitecan Investigated for use/treatment in pancreatic cancer, leukemia (unspecified), melanoma, ovarian cancer, and cancer/tumors (unspecified). MLN576 Investigated for use/treatment in solid tumors. Exatecan Exatecan has been used in trials studying the treatment of Sarcoma, Leukemia, Lymphoma, Lung Cancer, and Liver Cancer, among others. Belotecan Belotecan has been investigated for the treatment of Epithelial Ovarian Cancer. SN-38 Investigated for use/treatment in colorectal cancer. - Drugs & Drug Targets